These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35639541)

  • 41. The effect of prednisone on the progression from ocular to generalized myasthenia gravis.
    Monsul NT; Patwa HS; Knorr AM; Lesser RL; Goldstein JM
    J Neurol Sci; 2004 Feb; 217(2):131-3. PubMed ID: 14706214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis.
    Peric S; Rankovic M; Bozovic I; Radosavljevic V; Marjanovic I; Basta I; Lavrnic D
    Acta Neurol Belg; 2023 Apr; 123(2):529-536. PubMed ID: 36279094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HLA antigens and acetylcholine receptor antibody in the subclassification of myasthenia gravis in Hong Kong Chinese.
    Hawkins BR; Ip MS; Lam KS; Ma JT; Wy CL; Yeung RT; Dawkins RL
    J Neurol Neurosurg Psychiatry; 1986 Mar; 49(3):316-9. PubMed ID: 3958744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes of COVID-19 Infection and Vaccination Among Individuals With Myasthenia Gravis.
    Alcantara M; Koh M; Park AL; Bril V; Barnett C
    JAMA Netw Open; 2023 Apr; 6(4):e239834. PubMed ID: 37097637
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An evaluation of signs in ocular myasthenia gravis and correlation with acetylcholine receptor antibodies.
    Francis IC; Nicholson GA; Kappagoda MB
    Aust N Z J Ophthalmol; 1985 Nov; 13(4):395-9. PubMed ID: 3833299
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.
    Rivner MH; Pasnoor M; Dimachkie MM; Barohn RJ; Mei L
    Neurol Clin; 2018 May; 36(2):293-310. PubMed ID: 29655451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.
    Lindstrom JM; Seybold ME; Lennon VA; Whittingham S; Duane DD
    Neurology; 1976 Nov; 26(11):1054-9. PubMed ID: 988512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell-Based Versus Enzyme-Linked Immunosorbent Assay for the Detection of Acetylcholine Receptor Antibodies in Chinese Juvenile Myasthenia Gravis.
    Yan C; Li W; Song J; Feng X; Xi J; Lu J; Zhou S; Zhao C
    Pediatr Neurol; 2019 Sep; 98():74-79. PubMed ID: 31307830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
    Kupersmith MJ; Latkany R; Homel P
    Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myasthenia gravis associated with novel coronavirus 2019 infection: A report of three cases.
    Karimi N; Okhovat AA; Ziaadini B; Haghi Ashtiani B; Nafissi S; Fatehi F
    Clin Neurol Neurosurg; 2021 Sep; 208():106834. PubMed ID: 34329810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Seronegative myasthenia gravis].
    Gajdos P
    Rev Neurol (Paris); 2004 Feb; 160(2):159-62. PubMed ID: 15034472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prematurity and early-onset juvenile myasthenia gravis.
    Evans OB; Vig V; Parker CC
    Pediatr Neurol; 1992; 8(1):51-3. PubMed ID: 1558576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acetylcholine receptor antibody in the diagnosis of myasthenia gravis.
    Nicholson GA; McLeod JG; Griffiths LR
    Med J Aust; 1983 Oct; 2(7):334-7. PubMed ID: 6621466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoimmune myasthenia gravis and COVID-19. A case report-based review.
    Croitoru CG; Cuciureanu DI; Hodorog DN; Grosu C; Cianga P
    J Int Med Res; 2023 Aug; 51(8):3000605231191025. PubMed ID: 37565671
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
    Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
    Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early-onset myasthenia gravis.
    Roach ES; Buono G; McLean WT; Weaver RG
    J Pediatr; 1986 Feb; 108(2):193-7. PubMed ID: 3944702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors affecting outcome in ocular myasthenia gravis.
    Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
    Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Myasthenia gravis and muscle atrophy].
    Sanadze AG; Gilvanova OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(2):79-87. PubMed ID: 33728855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Temporal association between SARS-CoV-2 and new-onset myasthenia gravis: is it causal or coincidental?
    Muralidhar Reddy Y; B SK; Osman S; Murthy JMK
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34290032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.